연구

연구업적

최근 5년 연구업적 현황
연도 2024년 2023년 2022년 2021년 2020년
SCI 논문
발표편수
책임 179편 173편 163편 184편 135편
공동 147편 120편 115편 136편 168편
합계 326편 293편 278편 320편 303편
1617. Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.
Kim Y1, Bae JM2, Li G1, Cho NY2, Kang GH3.
PLoS One. 2015 Apr 15;10(4):e0122183. doi: 10.1371/journal.pone.0122183. eCollection 2015. Link
1616. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
Rhee YY1, Lee TH, Song YS, Wen X, Kim H, Jheon S, Lee CT, Kim J, Cho NY, Chung JH, Kang GH.
Virchows Arch. 2015 Jun;466(6):675-83. doi: 10.1007/s00428-015-1749-0. Epub 2015 Mar 13. Link
1615. Gastric-type expression signature in serrated pathway-associated colorectal tumors.
Kim JH1, Kim KJ2, Rhee YY2, Bae JM2, Cho NY3, Lee HS4, Kang GH5.
Hum Pathol. 2015 May;46(5):643-56. doi: 10.1016/j.humpath.2015.01.003. Epub 2015 Jan 15 Link
1614. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.
Bae JM1, Lee TH1, Cho NY1, Kim TY1, Kang GH1.
World J Gastroenterol. 2015 Feb 7;21(5):1457-67. doi: 10.3748/wjg.v21.i5.1457. Link
1613. Comparative validation of assessment criteria for Crohn-like lymphoid reaction in colorectal carcinoma.
Kim JH1, Kim KJ2, Bae JM2, Rhee YY2, Cho NY3, Lee HS4, Kang GH5.
J Clin Pathol. 2015 Jan;68(1):22-8. doi: 10.1136/jclinpath-2014-202603. Epub 2014 Oct 16. Link
1612. Clinical Performance of Whole-Body 18F-FDG PET/Dixon-VIBE, T1-Weighted, and T2-Weighted MRI Protocol in Colorectal Cancer
Lee SJ, Seo HJ, Kang KW, Jeong SY, Yi NJ, Lee JM, Chung JK, Edmund Kim E, Paeng JC, Cheon GJ, Lee DS
Clin Nucl Med. 2015 Aug;40(8):e392-8 Link
1611. Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma
Han JJ1, Kim TM, Jeon YK, Kim MK, Khwarg SI, Kim CW, Kim IH, Heo DS.
Ann Hematol. 2014 Oct 24. [Epub ahead of print] Link
1610. A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid Cancer
Lee HJ1, Heo DS, Cho JY, Han SW, Chang HJ, Yi HG, Kim TE, Lee SH, Oh DY, Im SA, Jang IJ, Bang YJ.
Cancer Res Treat. 2014 Jul;46(3):234-42. doi: 10.4143/crt.2014.46.3.234. Epub 2014 Jul 15. Link
1609. Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis.
Kim YJ1, Kim SJ, Lee JK, Choi WS, Park JH, Kim HJ, Sim SH, Lee KW, Lee SH, Kim JH, Kim DW, Lee JS, Bang YJ, Heo DS.
J Cancer Res Clin Oncol. 2014 Sep;140(9):1567-74. doi: 10.1007/s00432-014-1688-1. Epub 2014 May 4. Link
1608. Effect of cosmetic outcome on quality of life after breast cancer surgery
Kim MK, Kim T, Moon HG, Jin US, Kim K, Kim J, Lee JW, Kim J, Lee E, Yoo TK, Noh DY, Minn KW, Han W
Eur J Surg Oncol. 2014 Dec 19. [Epub ahead of print] Link